High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-231013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Patrik Mattsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Neocortex, Aminopyridines. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Deposits of amyloid-β (Aβ) appear early in Alzheimer’s disease (AD).
Objective
The aim of the present study was to compare the presence of cortical and subcortical Aβ in early AD using positron emission tomography (PET).
Methods
Eight cognitively unimpaired (CU) subjects, 8 with mild cognitive impairment (MCI) and 8 with mild AD were examined with PET and [11C]AZD2184. A data driven cut-point for Aβ positivity was defined by Gaussian mixture model of isocortex binding potential (BPND) values.
Results
Sixteen subjects (3 CU, 5 MCI and 8 AD) were Aβ-positive. BPND was lower in subcortical and allocortical regions compared to isocortex. Fifteen of the 16 Aβ-positive subjects displayed Aβ binding in striatum, 14 in thalamus and 10 in allocortical regions.
Conclusions
Aβ deposits appear to be widespread in early AD. It cannot be excluded that deposits appear simultaneously throughout the whole brain which has implications for improved diagnostics and disease monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden.
- PET Science Centre, Personalized Medicine and Biosamples, R&D, AstraZeneca, Stockholm, Sweden.
- Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
- School of Medicine, Örebro University, Örebro, Sweden.
- Department of Geriatrics, Örebro University Hospital, Örebro and Södertälje Hospital, Södertälje, Sweden.
- Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Mattsson, P., Cselényi, Z., Forsberg Morén, A., Freund-Levi, Y., Wahlund, L. O., Halldin, C., & Farde, L. (2024). High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231013
Vancouver
Mattsson P, Cselényi Z, Forsberg Morén A, Freund-Levi Y, Wahlund LO, Halldin C, et al. High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231013
BibTeX
@article{Mattsson2024,
author = {Mattsson, Patrik and Cselényi, Zsolt and Forsberg Morén, Anton and Freund-Levi, Yvonne and Wahlund, Lars-Olof and Halldin, Christer and Farde, Lars},
title = {High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-231013}
}
EUVIMED